These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 7828613)

  • 1. Assessment of cerebral perfusion with single-photon emission tomography in normal subjects and in patients with Alzheimer's disease: effects of region of interest selection.
    Claus JJ; van Harskamp F; Breteler MM; Krenning EP; van der Cammen TJ; Hofman A; Hasan D
    Eur J Nucl Med; 1994 Oct; 21(10):1044-51. PubMed ID: 7828613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HMPAO SPET and FDG PET in Alzheimer's disease and vascular dementia: comparison of perfusion and metabolic pattern.
    Mielke R; Pietrzyk U; Jacobs A; Fink GR; Ichimiya A; Kessler J; Herholz K; Heiss WD
    Eur J Nucl Med; 1994 Oct; 21(10):1052-60. PubMed ID: 7828614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterogeneity of neocortical cerebral blood flow deficits in dementia of the Alzheimer type: a [99mTc]-d,l-HMPAO SPECT study.
    Waldemar G; Bruhn P; Kristensen M; Johnsen A; Paulson OB; Lassen NA
    J Neurol Neurosurg Psychiatry; 1994 Mar; 57(3):285-95. PubMed ID: 8158175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain perfusion scintigraphy with 99mTc-HMPAO or 99mTc-ECD and 123I-beta-CIT single-photon emission tomography in dementia of the Alzheimer-type and diffuse Lewy body disease.
    Donnemiller E; Heilmann J; Wenning GK; Berger W; Decristoforo C; Moncayo R; Poewe W; Ransmayr G
    Eur J Nucl Med; 1997 Mar; 24(3):320-5. PubMed ID: 9143472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Choice of reference region in the quantification of single-photon emission tomography in primary degenerative dementia.
    Talbot PR; Lloyd JJ; Snowden JS; Neary D; Testa HJ
    Eur J Nucl Med; 1994 Jun; 21(6):503-8. PubMed ID: 8082664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Voxel-based comparison of rCBF SPET images in frontotemporal dementia and Alzheimer's disease highlights the involvement of different cortical networks.
    Varrone A; Pappatà S; Caracò C; Soricelli A; Milan G; Quarantelli M; Alfano B; Postiglione A; Salvatore M
    Eur J Nucl Med Mol Imaging; 2002 Nov; 29(11):1447-54. PubMed ID: 12397463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The diagnostic value of SPECT with Tc 99m HMPAO in Alzheimer's disease: a population-based study.
    Claus JJ; van Harskamp F; Breteler MM; Krenning EP; de Koning I; van der Cammen TJ; Hofman A; Hasan D
    Neurology; 1994 Mar; 44(3 Pt 1):454-61. PubMed ID: 8145915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regional differences between 99mTc-ECD and 99mTc-HMPAO SPET in perfusion changes with age and gender in healthy adults.
    Inoue K; Nakagawa M; Goto R; Kinomura S; Sato T; Sato K; Fukuda H
    Eur J Nucl Med Mol Imaging; 2003 Nov; 30(11):1489-97. PubMed ID: 14579088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noninvasive measurements of regional cerebral blood flow using technetium-99m hexamethylpropylene amine oxime.
    Matsuda H; Tsuji S; Shuke N; Sumiya H; Tonami N; Hisada K
    Eur J Nucl Med; 1993 May; 20(5):391-401. PubMed ID: 8519258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative technetium 99m hexamethylpropylene amine oxime SPET study in different types of dementia.
    Habert MO; Spampinato U; Mas JL; Piketty ML; Bourdel MC; de Recondo J; Rondot P; Askienazy S
    Eur J Nucl Med; 1991; 18(1):3-11. PubMed ID: 2019279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Memory functions and rCBF (99m)Tc-HMPAO SPET: developing diagnostics in Alzheimer's disease.
    Elgh E; Sundström T; Näsman B; Ahlström R; Nyberg L
    Eur J Nucl Med Mol Imaging; 2002 Sep; 29(9):1140-8. PubMed ID: 12192558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multi-institutional study of interobserver agreement in the evaluation of dementia with rCBF/SPET technetium-99m exametazime (HMPAO).
    Hellman RS; Tikofsky RS; Van Heertum R; Coade G; Carretta R; Hoffmann RG
    Eur J Nucl Med; 1994 Apr; 21(4):306-13. PubMed ID: 8005154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of (99m)Tc-HMPAO SPET changes in dementia with Lewy bodies and Alzheimer's disease using statistical parametric mapping.
    Colloby SJ; Fenwick JD; Williams ED; Paling SM; Lobotesis K; Ballard C; McKeith I; O'Brien JT
    Eur J Nucl Med Mol Imaging; 2002 May; 29(5):615-22. PubMed ID: 11976799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantification of regional cerebral blood flow (rCBF) using 99Tcm-HMPAO and SPECT: choice of the reference region.
    Syed GM; Eagger S; Toone BK; Levy R; Barrett JJ
    Nucl Med Commun; 1992 Nov; 13(11):811-6. PubMed ID: 1470423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional cerebral blood flow assessed with 99mTc-ECD SPET as a marker of progression of mild cognitive impairment to Alzheimer's disease.
    Encinas M; De Juan R; Marcos A; Gil P; Barabash A; Fernández C; De Ugarte C; Cabranes JA
    Eur J Nucl Med Mol Imaging; 2003 Nov; 30(11):1473-80. PubMed ID: 14579086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regional cerebral blood flow pattern in normal young and aged volunteers: a 99mTc-HMPAO SPET study.
    Catafau AM; Lomeña FJ; Pavia J; Parellada E; Bernardo M; Setoain J; Tolosa E
    Eur J Nucl Med; 1996 Oct; 23(10):1329-37. PubMed ID: 8781137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A study of regional cerebral blood flow using 99mTc-HMPAO-SPECT in elderly women with senile dementia of Alzheimer's type.
    Elmståhl S; Siennicki-Lantz A; Lilja B; Bjunö L
    Dementia; 1994; 5(6):302-9. PubMed ID: 7866483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A quantitative approach to technetium-99m ethyl cysteinate dimer: a comparison with technetium-99m hexamethylpropylene amine oxime.
    Matsuda H; Yagishita A; Tsuji S; Hisada K
    Eur J Nucl Med; 1995 Jul; 22(7):633-7. PubMed ID: 7498224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional cerebral blood flow measured by 99mTc-HMPAO SPECT differs in subgroups of Alzheimer's disease.
    Soininen H; Helkala EL; Kuikka J; Hartikainen P; Lehtovirta M; Riekkinen PJ
    J Neural Transm Park Dis Dement Sect; 1995; 9(2-3):95-109. PubMed ID: 8527009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new method for the relative quantification of rCBF examined by 99Tcm-HMPAO SPECT.
    Arlig A; Larsson A; Bergh AC; Jacobsson L; Wikkelsö C
    Nucl Med Commun; 1994 Oct; 15(10):814-23. PubMed ID: 7838445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.